Quadrature Capital Ltd Lowers Holdings in DaVita Inc. (NYSE:DVA)

Quadrature Capital Ltd reduced its holdings in shares of DaVita Inc. (NYSE:DVA) by 76.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,047 shares of the company’s stock after selling 6,767 shares during the period. Quadrature Capital Ltd’s holdings in DaVita were worth $336,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Quantinno Capital Management LP increased its position in shares of DaVita by 11.8% during the third quarter. Quantinno Capital Management LP now owns 17,394 shares of the company’s stock worth $2,851,000 after acquiring an additional 1,840 shares during the period. Quarry LP purchased a new position in DaVita in the third quarter valued at $60,000. Royal London Asset Management Ltd. grew its stake in DaVita by 1.9% during the 3rd quarter. Royal London Asset Management Ltd. now owns 20,684 shares of the company’s stock worth $3,391,000 after purchasing an additional 379 shares in the last quarter. Redwood Investment Management LLC increased its holdings in DaVita by 4.0% during the 3rd quarter. Redwood Investment Management LLC now owns 10,360 shares of the company’s stock worth $1,690,000 after purchasing an additional 402 shares during the period. Finally, Integrated Wealth Concepts LLC raised its position in DaVita by 81.5% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 9,915 shares of the company’s stock valued at $1,625,000 after purchasing an additional 4,452 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Barclays upped their target price on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial boosted their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, DaVita currently has a consensus rating of “Hold” and an average target price of $161.80.

Insider Activity at DaVita

In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $165.05, for a total value of $8,252,500.00. Following the completion of the sale, the chief executive officer now owns 837,835 shares in the company, valued at approximately $138,284,666.75. The trade was a 5.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.00% of the stock is owned by corporate insiders.

DaVita Price Performance

Shares of NYSE DVA opened at $158.05 on Tuesday. The stock’s 50-day simple moving average is $158.46 and its 200-day simple moving average is $150.52. The firm has a market capitalization of $12.96 billion, a PE ratio of 17.05, a price-to-earnings-growth ratio of 0.90 and a beta of 0.90. DaVita Inc. has a fifty-two week low of $103.40 and a fifty-two week high of $169.51. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the business posted $2.85 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. As a group, equities research analysts forecast that DaVita Inc. will post 9.71 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.